Peptides Are Exploding. Payments Isn’t Ready
Peptides Are Exploding. Payments Isn’t Ready. The Research-Peptide Market Is Growing Faster Than the Infrastructure Built to Underwrit...
Nutraceuticals are natural compounds with health-promoting or medicinal properties. This category includes vitamins, minerals, herbal supplements, animal products, and "functional foods" - food items claiming specific health benefits based on their ingredients.
Nutraceuticals, a term coined by Dr. Stephen DeFelice in 1989, refers to "food or part of a food that provides medical or health benefits, including the prevention and/or treatment of a disease." This definition, while accurate, is not officially recognized by any regulatory authority worldwide. The nutraceutical market is rapidly expanding, with consumers seeking cheaper alternatives to prescription medications and health products to supplement their dietary intake.
The global nutraceutical market is experiencing significant growth. In the United States alone, the FDA estimates that there are more than 85,000 dietary supplement products available. According to the National Health and Nutrition Examination survey (NHANES) data, approximately half of U.S. adults and one-third of children report using dietary supplements. Another study estimated that over 158 million Americans consume dietary supplements regularly to maintain or improve their health.
The regulation of nutraceuticals presents significant challenges due to the lack of a clear, globally accepted definition. Many countries classify these products into different categories based on their health claims. The primary challenge in regulating dietary supplements is the absence of international consensus on how this category of products is defined, and the lack of global standards to ensure quality and integrity.
The regulation of nutraceuticals varies globally, presenting challenges for international markets. While Japan defines functional foods by their natural ingredients, the U.S. allows biotechnology-derived components. Regulatory focus typically centers on safety and labeling, with less emphasis on product claims compared to pharmaceuticals.
Every country has a different approach to regulating or monitoring the production and sale of nutraceuticals.
In Australia, nutraceuticals fall under the category of "Therapeutic Goods," regulated by the Therapeutic Goods Act of 1989. The Therapeutic Goods Administration (TGA) oversees these products, which include complementary medicines such as herbs, vitamins, minerals, and other nutritional supplements. Australia uses a risk-based approach with a two-tiered system: low-risk medicines may be listed on the Australian Register of Therapeutic Goods (ARTG), while high-risk medicines must be registered and undergo evaluation for safety, efficacy, and quality.
Canada regulates nutraceuticals under the category of Natural Health Products (NHPs). The Natural Health Products Regulations came into effect on January 1, 2004, and since then, Health Canada has licensed over 43,000 products. NHPs include vitamins, minerals, herbal remedies, homeopathic medicines, traditional medicines, probiotics, and other products like amino acids and essential fatty acids. These products undergo a premarket approval process and require a license before entering the market.
Japan categorizes nutraceuticals as either "Foods in General" or "Food with Health Claims." Under "Food with Health Claims," there are three distinct categories: "Food with Nutrient Function Claims" (FNFC), "Food for Specified Health Uses" (FOSHU), and "Foods with Function Claims" (FFC). Japan was the first country to regulate food supplements by issuing the FOSHU system in 1991. The Ministry of Health, Labor, and Welfare is the main regulatory body for all drugs and health supplements in Japan.
In the United States, nutraceuticals are termed "Dietary Supplements" and are regulated under the Dietary Supplement Health and Education Act (DSHEA) of 1994. Unlike drugs, dietary supplements do not require premarket approval from the FDA. Manufacturers are responsible for ensuring product safety, and neither FDA approval nor registration is needed before sale. The FDA regulates these products primarily through post-market surveillance.
The safety of nutraceuticals is a growing concern due to the potential presence of contaminants, pesticides, and toxic chemicals resulting from manufacturing processes. Serious adverse effects, including hepatotoxicity, renal failure, and carcinogenicity, have been reported. Pesticides are considered the most dangerous nutraceutical contaminants, and heavy metals like lead, cadmium, mercury, and arsenic are also significant concerns.
Recent studies have reported numerous nutraceutical-drug interactions, some of which could be serious and life-threatening. For example, aspirin and some non-steroidal anti-inflammatory drugs interact with herbal products containing ginkgo, turmeric, ginger, ginseng, chamomile, and garlic, potentially increasing the risk of bleeding due to the inhibition of platelet aggregation.
Probiotics, now classified as nutraceuticals, are defined by the World Health Organization as "live microorganisms that when administered in adequate amounts confer a health benefit on the host." While some clinical studies suggest probiotics are safe due to the absence of toxicity in diverse populations, more research is required to support their recommendations for specific diseases.
Herbal medicines, which consist of whole plants or their parts, are regulated separately in some countries. For instance, in Japan, "Kampo Medicine" is classified as a medicine rather than a functional food and is considered equivalent to a government-regulated prescription drug.
Most countries regulate nutraceuticals as food products. Some regions have specific supplement or nutraceutical regulations. Market entry typically follows registration or notification-based systems.
Dr. Tomislav Meštrović, MD, Ph.D. notes, "Consumers are largely responsible for determining the usefulness and value offered by nutraceuticals. Still, increased regulation related to the quality and safety of these products will significantly benefit the industry and help mitigate the risk of regulatory backlash."
Global Variations
Latin America shows diverse approaches:
Some countries require additional studies: "In countries such as Brazil, China, and Taiwan, regulators require animal and/or human clinical studies as a requirement of the product registration process."
The notification-based approach is considered to balance pre-market resources, consumer access, and safety. However, robust post-market surveillance remains crucial for ensuring product quality and safety.
Despite regulations to improve the marketplace, many challenges remain. The quality and safety of available products can be highly variable, especially for herbal products. There is a need for continued efforts and improved techniques to assess the quality of dietary supplements, particularly regarding purity, bioavailability, and safety.
Establishing transparent analytical approaches with emerging technology will be crucial to ensure worldwide quality and safety of dietary supplements and herbal products. Furthermore, global regulatory agencies must engage in in-depth discussions about their regulatory principles to understand the effect on public health and work towards harmonization of nutraceutical regulation in a global context.
Qredible is dedicated to supporting businesses on a journey toward maximum safety in nutraceutical production and sales. Learn more about our products here on our site, and get in touch with us today to demo our elite software solutions.
